Stonington Global (Obo, Sorrento Therapeutics)
Consulting Firm, Biopharmaceutical Company
Based in MD
AI Overview
With $50K in lobbying spend across 5 quarterly filings, Stonington Global (Obo, Sorrento Therapeutics) is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $10K |
| 2021 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Stonington Global (Obo, Sorrento Therapeutics) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, MED, Health Issues, Budget/Appropriations
FDA Approvals, Department of Health and Human Services, Clinical Trials, NIH and FDA research.
COVID-19 FDA medication approvals
COVID-19 Relief
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.